HeadInvest LLC’s Fulgent Genetics FLGT Stock Holding History

HeadInvest LLC’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-368	Closed	-$9.9K	–	385
2023 Q3	$9.9K	Buy	+368	New	+$12.6K	﹤0.01%	556

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HeadInvest LLC's FLGT Position: Q4 2023 in Review

HeadInvest LLC sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 368 shares — an estimated $9.9K sold.

HeadInvest LLC first reported a position in FLGT in Q3 2023 and held it in 1 quarter. The position peaked at $9.9K in Q3 2023. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

HeadInvest LLC reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
HeadInvest LLC sold 368 Fulgent Genetics shares in Q4 2023, an estimated $9.9K.
HeadInvest LLC first reported a position in Fulgent Genetics in Q3 2023 and held it in 1 quarter.
HeadInvest LLC's Fulgent Genetics position peaked at $9.9K in Q3 2023.
196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on HeadInvest LLC's 13F filing for Q4 2023, filed 12 Feb 2024.